Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...
The investigators retrospectively evaluated 126 consecutive treatment-naïve nAMD patients (126 eyes) who received a loading ...
Ian Byrne has put the issue of NHS cataract surgeries being carried out by the independent sector forward for debate in the ...
Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.
Incorporating foods rich in certain vitamins and nutrients may help protect your vision and lower the risk of certain eye ...
Tomatoes are packed with vitamins, antioxidants, and minerals that support heart health, skin health, immunity, and digestion ...
13h
GlobalData on MSNOcugen receives DSMB approval to continue dosing in Phase I trial of OCU200US-based biotechnology company Ocugen has received approval from the Data and Safety Monitoring Board (DSMB) to begin dosing the second cohort of patients in a Phase I trial of OCU200, a fusion ...
Kalaris is focused on developing TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative dis ...
Telomir-1 shows potential in oncology and age-related diseases, with new findings on its role in tumor suppression and ...
Chinese companies are involved in one-fifth of pharma’s clinical development programs, but trade wars and regulatory hurdles ...
But people have been warned that it's not a silver bullet against cholesterol, and in the wrong amount, it can make matters ...
At 92 and blind, Babbie Lovett remains committed to fashion, guided by her sense of touch -- and by what seems like an almost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results